Medicine Use Reviews (MURs) aim to improve patients' adherence and experience of using their medication(s), maximise the benefits and reduce waste due to unused medicines. Pharmacies are paid £28 for each MUR undertaken, up to a maximum of 400 per pharmacy, per year.
During the MUR consultation, the pharmacist establishes the patient's experience of taking their medicines, assisting in cases of poor or ineffective use and working with the patient to resolve any problems (such as side effects or interactions). The pharmacist will consider all the medicines taken by the patient, including those which aren't prescribed.
Pharmacies should ensure that at least seventy per cent of their MURs are carried out on patients in one (or more) of the four target groups:
- patients taking certain high risk medicine(s) (on a national list)
- patients recently discharged from hospital with changes to their prescribed medicine(s)
- patients with a respiratory condition such as asthma or COPD
- patients with cardiovascular disease or risk factors, who are prescribed four or more regular medicines.
Pharmacists can also provide up to thirty per cent of their MURs to patients who are not within the target groups, provided they meet certain conditions and it is the pharmacist's clinical judgement that the patient will benefit from the service.
NHS Employers and the Pharmaceutical Services Negotiating Committee (PSNC) have developed a number of resources for pharmacies and commissioners to support provision of the MUR service:
- The MUR Guidance covers all aspects of providing the service (please note that this was last updated in 2013 and does not include the high risk target group or the increased target percentage, which were introduced in 2015).
- NMS and MUR top tips from community pharmacies, giving tried and tested advice on overcoming some common challenges.
- Medicines Reconciliation video, showing the benefits for patients when hospitals and community pharmacies work together to support patients when they are discharged from hospital.
- MUR data definitions document - for support completing the MUR reporting template for submission on request to NHS England.
The legal basis for the service is the Pharmaceutical Services (Advanced and Enhanced Services) (England) Directions 2013
, as amended. These directions have been amended a number of times since publication. The Amendment Directions are published in the drug tariff
for the month they came into effect.
MUR data and reporting requirements
Details of MUR data and reporting requirements can be found on the Department of Health website. These requirements include:
- Data to be collected during the consultation.
- Information to be sent to NHS England (previously Primary Care Trusts) on request. For assistance completing this template please see the MUR data definitions document.
- A requirement to inform the patient's GP only if an issue has been raised that the pharmacist believes the GP needs to be aware of. A form has been produced for this purpose, developed by NHS Employers, Pharmaceutical Services Negotiating Committee (PSNC) and the General Practitioners Committee (GPC) of the British Medical Association (BMA).